Government shutdown having major effect on FDA
WASHINGTON — The U.S. Food and Drug Administration has roughly five weeks of funding left to review new drug applications during the shutdown, commissioner Dr. Scott Gottlieb reported this past week on Twitter. Many experts predict this could have a ripple effect, bogging down the approval and manufacture of new drugs, delaying patients from getting these treatments and
